Home API Atracurium CS-O-00905

Atracurium besylate

API API Family: Atracurium CAT No. CS-O-00905 CAS No. 64228-81-5
In Stock
Product Detail

Atracurium besylate

Atracurium API
Stock Status: In Stock   Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category API
API Family Atracurium
Storage Store at refrigerator (2-8°C) for long term storage
Hazard Information Refer MSDS for accurate information.

Atracurium besylate Product Information

Atracurium besylate is listed under API. It is associated with Atracurium and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-00905.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Technical Data

Product Name
Atracurium besylate
CAS No.
64228-81-5
CAT No.
CS-O-00905
Molecular Formula
C65H82N2O18S2
Molecular Weight
1243.49
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C(OCCCCCOC(CC[N+]1(C)CCC2=CC(OC)=C(OC)C=C2C1CC3=CC=C(OC)C(OC)=C3)=O)CC[N+]4(C)CCC5=CC(OC)=C(OC)C=C5C4CC6=CC=C(OC)C(OC)=C6.O=S([O-])(C7=CC=CC=C7)=O.O=S([O-])(C8=CC=CC=C8)=O
IUPAC Name
2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfonate
Purity by HPLC
>98%
Hazard Compound
Refer MSDS for accurate information.

Description

Overview
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alterna
Synonyms
Tracrium
Application Notes
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alterna
References
"Hughes; R,; et al,: Br, J, Anaesth,; 53; 31 (1981); Basta; S,J,; et al,: Anesth, Analog,; 61; 723 (1982); Neill; E,A,; et al,: Xenobiotca; 12; 203 (1982);"
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.